The core research effort currently funded by Cure Alzheimer’s Fund is the  Alzheimer's Genome Project™ (AGP) initiative, led by Dr. Tanzi, which has the objective of identifying all relevant remaining Alzheimer’s genes that have not yet been discovered, thereby identifying more targets for the development of therapeutic interventions. Other research projects related to the AGP, funded by Cure Alzheimer’s Fund, are:

Alzheimer’s Disease Brain-Genetic Study

This program, led by Dr. Bradley Hyman (MIND), compares the pathological features of autopsied brains of deceased AD patients with those of non-demented subjects to link AD pathology to genetic factors.

Alzheimer’s Disease Clinical-Genetic Study

This program, headed by Dr. Deborah Blacker (MGH), tracks patients with “benign forgetfulness,” mild cognitive impairment and AD using imaging and cognitive tests to link clinical feature of AD to genetic factors.

Alzheimer’s Disease Gene Database

This Internet database and forum, headed by Dr. Lars Bertram (MIND), gathers and analyzes all published studies and data relating to AD genetics, and provides weekly updates regarding ongoing attempts to identify novel AD genes.